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Cherubism is a rare benign, non-neoplastic condition character-
ized by facial alteration due to symmetrically expansion of bilat-
eral mandibles and maxillas. A fine-needle aspiration of a right
cheek mass was performed in a 17-year-old teenager who was
previously diagnosed Cherubism. The smears showed moderate
cellularity with spindle cells mixed with multinucleated giant cells
of osteoclast type. The cells appeared bland with normal nuclear/
cytoplasm ratio. The nuclei were round or oval with smooth nu-
clear membranes and fine, evenly distributed chromatin. These
cytologic features were considered consistent with but not diagnos-
tic of Cherubism. Clinical correlations are needed in distinguish-
ing Cherubism from other lesions containing giant cells. Diagn.
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Cherubism is a rare benign, non-neoplastic condition
characterized by facial alteration due to symmetrically
expansion of bilateral mandibles and maxillas with or
without involvement of other facial bones.1 The disorder
is generally inherited in an autosomal dominant fashion
with different penetrances in males (100%) and females
(50–70%).2 Sporadic cases as well as those associated
with other genetic disorders, such as Noonan-like syn-
drome and Ramon syndrome, have been reported.1,3,4
Classically, the disease is self-limited with initial manifes-
tation of apparent facial alteration during early childhood.
The lesions then progress till puberty and begin to regress
after puberty. Facial appearance may return to almost nor-
mal by the 4th or 5th decade. Gene mutations of SH3BP2
on chromosome 4p16.3 causing dysfunction of Msx-1
gene, a gene regulating mesenchymal interaction in cra-
niofacial morphogenesis, are proposed as the mechanism
of familial Cherubism.5 Such mutations also have been
found in rare isolated nonfamilial Cherubism.6 There are
no prior reports on cytologic features of Cherubism to the
best of our knowledge.
A 17-year-old male with a previous diagnosis of Cher-
ubism presented with a newly developed right cheek
mass. The mass measured 2 cm. It was well-demarcated,
firm, and nontender. A superficial fine-needle aspiration
was performed using a 25-gauge needle. A total of three
passes were obtained and six direct smears were made.
Half of the smears were air-dried and stained with Diff-
Quik. The remaining smears were rapidly fixed by the
SprayfixTM and stained with Papanicolaou technique. The
smears were moderately cellular with bland spindle cells
mixed with multinucleated giant cells of osteoclast type.
Fragments of fibrous stroma were present in the back-
ground (Figs. 1A and B). The spindle cells, as well as
giant cells had abundant cytoplasm and the nuclear/cyto-
plasm ratio remained within normal range. The nuclei
were round or oval with smooth nuclear membranes and
fine evenly distributed chromatins. Nucleoli were conspic-
uous (Figs. 1C and D). These features were considered
consistent with patient’s history of Cherubism.
Cytologic features of Cherubism have not been previ-
ously described to the best of our knowledge, although
histology of this disease has been studied.1 Histologically,
the lesion contains unevenly distributed multinucleated
giant cells and vascular spaces in variably cellular fibrous
stroma. An eosinophilic perivascular cuffing is seen some-
times which is valuable for diagnosis of Cherubism.1
Cytologic features of the current case almost mirrored his-
tology findings except that the rich vasculature was not
appreciated. Similar to histology, the cytologic finding of
osteoclast-type giant cells is nonspecific. Other lesions
containing giant cells such as central giant cell granu-
loma, peripheral giant cell granuloma, brown tumor of
hyperparathyroidism, giant cell tumor, and aneurysmal
bone cyst as well as infectious and foreign-body type
granulomatous inflammation should be included in the
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differential diagnoses. It is impossible to differentiate
Cherubism from the other entities mentioned earlier by
morphology alone. However, the clinical presentations
such as mainly inherited disorder, onset in early child-
hood, bilateral facial bone involvement only, and self-lim-
iting after puberty are unique for Cherubism. Unlike hy-
perparathyroidism, which presents with elevated serum
levels of calcium, phosphorus, alkaline phophatase, and
parathyroid hormone, the levels of these biomarkers are
usually within normal ranges in Cherubism. Further, DNA
testing for mutation in the SH3BP2 gene may play an im-
portant role in the identification of Cherubism. In short,
there is no unique cytological feature or ancillary test that
is specific for diagnosing Cherubism, the clinical correla-
tion is paramount in distinguishing Cherubism from the
others. Cherubism is graded according to location of
lesion and degree of expansion. Treatment includes medi-
cal therapy and surgical procedure based upon the known
natural course of the disease and the clinical behavior of
the individual case.1
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Fig. 1. Direct smears showing moderately cellularity with bland spindle cells mixed with multinualeated giant cells of osteoclast type. Fragments of
fibrous stroma were present in the background (A and B, Diff-Quik and Papanicolaou stain, respectively; 3100). Multinucleated giant cells with round
or oval nuclei, smooth nuclear membranes and fine, evenly distributed chromatins and conspicuous nucleoli (C and D, Papanicolaou stain; 3400).
[Color figure can be viewed in the online issue, which is available at www.interscience.wiley.com.]
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